BOT was valued at 250 mill pre phase 2 results .. with no 1801 plan..
Now with a phase 3 pathway and an antibiotic phase 2A trial we are valued at 50 mill?
What a bargain..
BOT was valued at 250 mill pre phase 2 results .. with no 1801...
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $687.8M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 6698 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 9000 | 1 |
View Market Depth
| Last trade - 09.32am 16/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |
Day chart unavailable